These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6226991)

  • 1. [Symmetrical peripheral gangrene: 4 cases].
    Smaoui F; Koubaa M; Rekik K; Mejdoub Y; Mezghani S; Maaloul I; Hammami A; Marrakchi C; Ben Jemaa M
    Ann Dermatol Venereol; 2018 Feb; 145(2):95-99. PubMed ID: 29169658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Mediterranean Spotted Fever with Cerebral Infarction.
    Binay UD; Barkay O; Karakeçili F; Gül Ö; Tanoğlu C; Sümer B
    Vector Borne Zoonotic Dis; 2024 Jul; 24(7):451-452. PubMed ID: 38608220
    [No Abstract]   [Full Text] [Related]  

  • 3. Mediterranean spotted fever.
    Brufau-Cochs M; Alamon-Reig F
    Med Clin (Barc); 2024 May; 162(10):e41. PubMed ID: 38151367
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal Involvement in Mediterranean Spotted Fever: Clinical and Histopathological Data.
    Baltadzhiev I; Zaprianov Z; Baltadjiev A
    Med Princ Pract; 2021; 30(4):369-375. PubMed ID: 33780958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediterranean spotted fever in the elderly: a prospective cohort study.
    Espejo E; Andrés M; Garcia MC; Fajardo A; Mauri M; Pérez J; Bella F
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1333-1337. PubMed ID: 30972588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Cohort Study of Single-Day Doxycycline Therapy for Mediterranean Spotted Fever.
    Espejo E; Andrés M; Garcia MC; Fajardo A; Pérez J; Bella F
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant forms of Mediterranean spotted fever: risk factors for fatal outcomes.
    Baltadzhiev I; Popivanova N; Zaprianov Z
    Braz J Infect Dis; 2016; 20(5):511-2. PubMed ID: 27453284
    [No Abstract]   [Full Text] [Related]  

  • 8. Host, pathogen and treatment-related prognostic factors in rickettsioses.
    Botelho-Nevers E; Raoult D
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1139-50. PubMed ID: 21519943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts.
    Parola P; Paddock CD; Raoult D
    Clin Microbiol Rev; 2005 Oct; 18(4):719-56. PubMed ID: 16223955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma interleukin-6 levels in Mediterranean spotted fever.
    Oristrell J; Sampere M; Amengual MJ; Font B; Segura F
    Eur J Clin Microbiol Infect Dis; 2004 May; 23(5):417-8. PubMed ID: 15103526
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and laboratory characteristics of 144 patients with mediterranean spotted fever.
    Antón E; Font B; Muñoz T; Sanfeliu I; Segura F
    Eur J Clin Microbiol Infect Dis; 2003 Feb; 22(2):126-8. PubMed ID: 12627290
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant boutonneuse fever and polymyalgia rheumatica: a coincidental association?
    Chaumentin G; Zénone T; Bibollet C; Denoyel GA; Boibieux A; Biron F; Peyramond D
    Infection; 1997; 25(5):320-2. PubMed ID: 9334871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of T-cell-dependent and -independent antigens of Rickettsia conorii with monoclonal antibodies.
    Feng HM; Walker DH; Wang JG
    Infect Immun; 1987 Jan; 55(1):7-15. PubMed ID: 3793235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin therapy for Mediterranean spotted fever.
    Raoult D; Gallais H; De Micco P; Casanova P
    Antimicrob Agents Chemother; 1986 Oct; 30(4):606-7. PubMed ID: 3789693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever.
    Muñoz-Espin T; López-Parés P; Espejo-Arenas E; Font-Creus B; Martinez-Vila I; Travería-Casanova J; Segura-Porta F; Bella-Cueto F
    Arch Dis Child; 1986 Oct; 61(10):1027-9. PubMed ID: 3535687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in Mediterranean spotted fever.
    Segura-Porta F; Font-Creus B; Espejo-Arenas E; Bella-Cueto F
    Eur J Epidemiol; 1989 Dec; 5(4):438-43. PubMed ID: 2691273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.
    Gudiol F; Pallares R; Carratala J; Bolao F; Ariza J; Rufi G; Viladrich PF
    Antimicrob Agents Chemother; 1989 Jun; 33(6):987-8. PubMed ID: 2669629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscular damage in Mediterranean spotted fever.
    Bella F; Espejo E; Bella MR; Font B; Ferrer I; Segura F
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):928-9. PubMed ID: 2512144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant form of Mediterranean boutonneuse fever. 6 cases].
    Raoult D; Gallais H; Ottomani A; Resch JP; Tichadou D; De Micco P; Casanova P
    Presse Med; 1983 Oct; 12(38):2375-8. PubMed ID: 6226991
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.